相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Gjin Ndrepepa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha
Meifang Han et al.
JOURNAL OF BIOCHEMISTRY (2008)
Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis
Itay Shalev et al.
JOURNAL OF IMMUNOLOGY (2008)
Peri-procedural myocardial injury: 2005 update
J Herrmann
EUROPEAN HEART JOURNAL (2005)
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B
Chuan-Long Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts
M Mendicino et al.
CIRCULATION (2005)
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection
Q Ning et al.
JOURNAL OF IMMUNOLOGY (2005)
Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction - Efficacy of distal protection device
A Okamura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Endothelial induction of Fg12 contributes to thrombosis during acute vascular xenograft rejection
A Ghanekar et al.
JOURNAL OF IMMUNOLOGY (2004)
No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion
T Reffelmann et al.
CIRCULATION (2003)
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
FS Resnic et al.
AMERICAN HEART JOURNAL (2003)
Fundamentals of reperfusion injury for the clinical cardiologist
S Verma et al.
CIRCULATION (2002)
Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion
T Reffelmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
The no-reflow phenomenon: basic science and clinical correlates
T Reffelmann et al.
HEART (2002)
The coronary no-reflow phenomenon: a review of mechanisms and therapies
E Eeckhout et al.
EUROPEAN HEART JOURNAL (2001)
Genomic characterization, localization, and functional expression of FGL2 the human gene encoding fibroleukin:: A novel human procoagulant
S Yuwaraj et al.
GENOMICS (2001)
分享论文
